Detalles de la búsqueda
1.
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
Lancet
; 403(10432): 1164-1175, 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402887
2.
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
Lancet Infect Dis
; 23(9): 1062-1071, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37178706
3.
A case report of successful complex percutaneous coronary intervention for acute coronary syndrome in a paediatric patient with familial hypercholesterolaemia.
Eur Heart J Case Rep
; 5(6): ytab175, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34142008
4.
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.
Sci Immunol
; 6(61)2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34266981
Resultados
1 -
4
de 4
1
Próxima >
>>